Biologists have identified important components and mechanisms of the molecular machinery that transmits information about a pathogen encounter within the plant organism.
The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 OncoSignature assay designed to detect endometrial cancer ...
BIO CEO & Investor Conference Format: "IPO Class of 2024 Panel" and one-on-one meetings Date: February 10, 2025 Location: New York, NY Registered conference attendees may schedule one-on-one meetings ...
Plant pests such as bacteria and fungi lead to significant yield losses in agriculture. In order to develop new strategies ...
Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a ...
Zentalis Pharmaceuticals, Inc.’s ZNTL share price has surged by 31.29%, which has investors questioning if this is right time to sell.
Pfizer has announced that its Braftovi (encorafenib) regimen significantly improved both progression-free and overall ...
Drug major Pfizer Inc. (PFE) announced Monday positive topline results from the progression-free survival or PFS analysis of the ...
Chemotherapeutic agents are often used to treat cancer. They combat tumor growth, but also have a number of undesirable side ...
1d
Zacks.com on MSNPFE's Colorectal Cancer Drug Meets Other Dual Primary Goal of PFSPfizer PFE announced positive top-line results from the progression-free survival (PFS) analysis of a late-stage study of its ...
Equities researchers at StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results